Analysis and commentary on current events around the world.
Joshua Van earned a unanimous decision (49-46, 49-47, 50-45) win over his Brazilian opponent to cement his reign.
Reporters from CNN, MS NOW and Politico have been denied White House access after Donald Trump banned the three outlets.
About 3.8 million voters in Berlin and Mecklenburg-Western Pomerania are heading to polls on Sunday.
Defence and tech companies have been taking part in annual exercises in Norway.
Selected by Beijing in 1996, Tung Chee-hwa's tenure shaped post-colonial Hong Kong during a turbulent political era.
The protest comes as the health of one detainee deteriorates after more than a month on hunger strike.
The US recalled a billion products off the market in just six months.
Saudi Arabia on Saturday said that Yemen's Houthi rebels tried to attack Riyadh with a ballistic missile, the first time the Saudi capital has been targeted since the escalation in fighting with the I
After its 2021 defeat, the party with an Islamic reference is rebuilding under Abdelilah Benkirane. Can it regain trust?
Ed Sheeran opened a solo concert Saturday with comments about Gaza after controversy swirled around his tour and supporting acts withdrew in solidarity with opener Macklemore, who was dropped after ma
Ed Sheeran has addressed the Macklemore-Palestine fallout in remarks at his solo concert in Philadelphia.
Peruvian journalist ‘China Polo’ has been shot dead a week after receiving death threats over a police investigation.
The British singer addresses fans at his concert in Philadelphia as his US Loop Tour resumes.
PM Anthony Albanese asks Apple CEO Tim Cook to back Canberra's online safety laws to 'keep Australians safe'.
Dozens were killed and injured in an attack by an armed group in a northwestern city.
DR Congo is rolling out vaccine trials for health workers at the centre of the country’s Ebola crisis.
Former Chilean President Michelle Bachelet ends her bid to be the first woman to lead the United Nations.
50,000 frontline staff to receive a jab for a different Ebola strain, with 20,000 enrolled in a one-year clinical trial.